November 17, 2023 | Vensana Capital® Portfolio News

Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A